AU2003248955A8 - Screening method - Google Patents

Screening method

Info

Publication number
AU2003248955A8
AU2003248955A8 AU2003248955A AU2003248955A AU2003248955A8 AU 2003248955 A8 AU2003248955 A8 AU 2003248955A8 AU 2003248955 A AU2003248955 A AU 2003248955A AU 2003248955 A AU2003248955 A AU 2003248955A AU 2003248955 A8 AU2003248955 A8 AU 2003248955A8
Authority
AU
Australia
Prior art keywords
screening method
screening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003248955A
Other versions
AU2003248955A1 (en
Inventor
Stuart Russel Maudsley
Ulrich Conrad Dyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ardana Bioscience Ltd
Original Assignee
Ardana Bioscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0216960A external-priority patent/GB0216960D0/en
Priority claimed from GB0308890A external-priority patent/GB0308890D0/en
Application filed by Ardana Bioscience Ltd filed Critical Ardana Bioscience Ltd
Publication of AU2003248955A1 publication Critical patent/AU2003248955A1/en
Publication of AU2003248955A8 publication Critical patent/AU2003248955A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003248955A 2002-07-22 2003-07-22 Screening method Abandoned AU2003248955A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0216960.5 2002-07-22
GB0216960A GB0216960D0 (en) 2002-07-22 2002-07-22 Screening method
GB0308890A GB0308890D0 (en) 2003-04-17 2003-04-17 Screening method
GB0308890.3 2003-04-17
PCT/GB2003/003231 WO2004010145A2 (en) 2002-07-22 2003-07-22 Screening method

Publications (2)

Publication Number Publication Date
AU2003248955A1 AU2003248955A1 (en) 2004-02-09
AU2003248955A8 true AU2003248955A8 (en) 2004-02-09

Family

ID=30772046

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003248955A Abandoned AU2003248955A1 (en) 2002-07-22 2003-07-22 Screening method

Country Status (2)

Country Link
AU (1) AU2003248955A1 (en)
WO (1) WO2004010145A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006040337A1 (en) * 2004-10-13 2006-04-20 Evotec Technologies Gmbh Method for identifying compounds that affect a transport of a protein through a membrane trafficking pathway

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4138621A1 (en) * 1991-11-25 1993-06-17 Boehringer Ingelheim Int METHOD FOR SCREENING SUBSTANCES WITH MODULATING EFFECT ON A RECEPTACLE-RELATED CELLULAR SIGNAL TRANSMISSION PATH
IL152011A0 (en) * 2000-04-15 2003-04-10 Medical Res Council Type ii gonadotropin-releasing hormone and polynucleotides encoding therefor
PT1512016E (en) * 2002-07-22 2006-06-30 Ardana Bioscience Ltd METHOD OF RESEARCH AND ANTITUMORAL PHARMACY CANDIDATE OBTAINED FROM THE SAME

Also Published As

Publication number Publication date
AU2003248955A1 (en) 2004-02-09
WO2004010145A3 (en) 2004-04-29
WO2004010145A2 (en) 2004-01-29

Similar Documents

Publication Publication Date Title
GB0213951D0 (en) Screening apparatus
EP1378749A4 (en) Screening method
GB0208104D0 (en) Method
GB0203306D0 (en) Method
AU2003258070A8 (en) Electrodionization method
AU2003277663A1 (en) Screening method
GB0111004D0 (en) Screening method
GB0304993D0 (en) Novel screening method
GB0205509D0 (en) Method
EP1514930A4 (en) Novel screening method
GB0204387D0 (en) Screening process
GB0209296D0 (en) Method
EP1491207A4 (en) Novel screening method
EP1669446A4 (en) Screening method
GB0205755D0 (en) Screening method
AU2003248955A8 (en) Screening method
GB0208383D0 (en) Method
GB0200865D0 (en) Method
GB0216960D0 (en) Screening method
GB0203924D0 (en) Screening method
GB0202921D0 (en) Screening method
GB0202263D0 (en) Screening method
EP1580266A4 (en) Screening method
GB0227082D0 (en) Method for screening
GB0302700D0 (en) Screening method

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase